newsfilter
← Latest News
Business Wire·

Anaergia Reports 30% Revenue Growth and Expands Revenue Backlog1 to $303 million in Third Quarter

ANRGF
  • Anaergia reported Q3 2026 revenue of $66.9 million, a 30.3% increase year-over-year.
  • The company secured approximately $86 million in new contract awards across Europe, North America, & Australia.
  • Revenue Backlog increased to $303.1 million, up 10.3% from June 30, 2026.
  • Adjusted EBITDA was positive for the fifth consecutive quarter, rising to $3.1 million in Q3 2026.
  • Net Income turned positive to $19.5 million in Q3 2026, compared to a $0.5 million loss in the prior-year period.
  • The divestiture of the Charlotte Bioenergy Facility & Rhode Island Bioenergy Facility interests generated a $21.9 million gain.
  • Project-level debt was reduced by US$20 million following the sale of the Charlotte & Rhode Island assets.
  • For the nine months ended September 30, 2026, revenue increased 71.5% to $186.0 million.
  • Year-to-date Net Income improved to $13.1 million, contrasting with a $15.8 million loss in the same period of 2025.
  • Gross profit for Q3 2026 reached $16.4 million, an 11.0% increase from the previous year.
  • Management cited the disposal of non-core assets as a strategic move to eliminate negative earnings contributions & focus on profitable growth.
  • A conference call to review these results is scheduled for November 12, 2026, at 9:30 a.m. EST.